We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry

Scope

Coding, payment mechanism tariffs

Countries
14 EU
Pricing
On request
Availability
On-demand
Scope

Pathway to create or improve reimbursement situation

Countries
14 EU
Pricing
On request
Availability
On-demand
Scope

Stakeholders, money flow, payment model, HTA landscape, funding, reimbursement pathway

Countries
14 EU
Pricing
1500€
Availability
Off-the-shelf
Scope

One day, on-site training on key aspects of market access

Countries
14 EU
Pricing
5000€
Availability
On-demand
Scope

Coding, payment mechanism tariffs for a specific procedure

Countries
11 EU
Pricing
On request
Availability
Off-the-shelf

Why us?

Analyses from the same vendor for 14 different EU countries
Analyses from the same vendor for 14 different EU countries

Save money and time, get standardized analysis

Pharma approach is put aside
Pharma approach is put aside

Work with a company truly specialized in medical devices and diagnostics

Getting results instantly (reports) or within 4-8 weeks (services)
Getting results instantly (reports) or within 4-8 weeks (services)

Make business decisions quickly

12 out of top-30 companies choose MTRC for reimbursement support
12 out of top-30 companies choose MTRC for reimbursement support

Work with a provider who understand industry’s needs

More than 110 projects accomplished during the last year
More than 110 projects accomplished during the last year

Work with a provider who has experience in your field

Team of 15 specialists in 6 countries
Team of 15 specialists in 6 countries

Work with a provider with a Pan-European capacity

More than 200 internal instructions and protocols
More than 200 internal instructions and protocols

Be sure about quality of the results

To stay up-to-date, we daily monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get updates every 2nd week

01 Jun 2018
European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.

13

Nov 2018

In October, Danish Health Authority published new codes for the Health Care Classification System, including one surgical, nine medical codes and two codes for ultrasound diagnostics. These codes are used to classify procedures in the Danish DRG system.

12

Nov 2018

On the 1st of October of 2018, the Russian Ministry of Health has released the Order № 665n about the extension of the list of transplantation objects with inclusion of hematopoietic stem cells.

09

Nov 2018

Two mini-method assessments regarding the magnetic technology (Magseed) for labeling non-palpable breast lesions and robotic-assisted minimally invasive harvesting of muscle patches for reconstructive surgery were initiated in Norway this October of 2018. All finalized mini-method assessments are published in the National Database for Mini-HTA.

08

Nov 2018

On October 26, 2018, the French High Authority for Health (HAS) has announced that the composition of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS) has been renewed.

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 14 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

Check our specific propositions for: Med Tech industry, IVD industry, Investors

Our services cover 18 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

In-vitro diagnostic tests

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring and insulin injection, use of fusidial markers, radiotherapy, endoscopy and more

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Atherectomy for peripheral artery disease
  • Brachytherapy
  • Combined report for minimally invasive and transcatheter mitral valve repair and replacement procedures for mitral regurgitation
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation
  • Minimally-invasive replacement of mitral valve for mitral regurgitation
  • Minimally-invasive reshaping of heart geometry for mitral regurgitation
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Proton Therapy
  • Robotic surgery interventions
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter annuloplasty ring for mitral regurgitation
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral annuloplasty using implant placed in the coronary sinus for mitral regurgitation
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Transcatheter mitral valve repair using mitral annulus plication for mitral regurgitation
  • Transcatheter mitral valve replacement
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Bariatric surgery
  • Cochlear implants for hearing loss
  • Deep brain stimulation
  • Gastric electrical stimulation for gastroparesis and obesity
  • Hernia repair
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators
  • Inferior Vena Cava Filter
  • Lung volume reduction for emphysema
  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Peripheral intravascular ultrasound
  • Vagus nerve stimulation